Treatment change in pregnancy is a significant risk factor for detectable HIV-1 RNA in plasma at end of pregnancy

M Floridia; M Ravizza; Carmela Pinnetti; C Tibaldi; A Bucceri; G Anzidei; M Fiscon; Alessandra Molinari; P Martinelli; S Dalzero; Enrica Tamburrini

doi:10.1310/hct1106-303

Treatment change in pregnancy is a significant risk factor for detectable HIV-1 RNA in plasma at end of pregnancy

M Floridia
, M Ravizza
, Carmela Pinnetti
, C Tibaldi
, A Bucceri
, G Anzidei
, M Fiscon
, Alessandra Molinari
, P Martinelli
, S Dalzero
, Enrica Tamburrini

Research output: Contribution to journal › Article

19 Citations (Scopus)

Abstract

To investigate the risk factors for an HIV-1 RNA plasma viral load above 400 copies/mL in the third trimester of pregnancy.

Original language	English
Pages (from-to)	303-311
Number of pages	9
Journal	HIV Clinical Trials
Volume	11
Issue number	6
DOIs	https://doi.org/10.1310/hct1106-303
Publication status	Published - 2010

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Adult
Anti-Retroviral Agents
CD4 Lymphocyte Count
Cohort Studies
Drug Administration Schedule
Female
HIV Infections
HIV-1
Humans
Infant
Infectious
Infectious Disease Transmission
Logistic Models
Newborn
Pregnancy
Pregnancy Complications
Pregnancy Trimester
RNA
Risk Factors
Third
Time Factors
Vertical
Viral
Viral Load
Withholding Treatment
Young Adult

Access to Document

10.1310/hct1106-303

Cite this

@article{0d89bffeae504754a1b9055812f8cbaa,

title = "Treatment change in pregnancy is a significant risk factor for detectable HIV-1 RNA in plasma at end of pregnancy",

abstract = "To investigate the risk factors for an HIV-1 RNA plasma viral load above 400 copies/mL in the third trimester of pregnancy.",

keywords = "Adult, Anti-Retroviral Agents, CD4 Lymphocyte Count, Cohort Studies, Drug Administration Schedule, Female, HIV Infections, HIV-1, Humans, Infant, Infectious, Infectious Disease Transmission, Logistic Models, Newborn, Pregnancy, Pregnancy Complications, Pregnancy Trimester, RNA, Risk Factors, Third, Time Factors, Vertical, Viral, Viral Load, Withholding Treatment, Young Adult, Adult, Anti-Retroviral Agents, CD4 Lymphocyte Count, Cohort Studies, Drug Administration Schedule, Female, HIV Infections, HIV-1, Humans, Infant, Infectious, Infectious Disease Transmission, Logistic Models, Newborn, Pregnancy, Pregnancy Complications, Pregnancy Trimester, RNA, Risk Factors, Third, Time Factors, Vertical, Viral, Viral Load, Withholding Treatment, Young Adult",

author = "M Floridia and M Ravizza and Carmela Pinnetti and C Tibaldi and A Bucceri and G Anzidei and M Fiscon and Alessandra Molinari and P Martinelli and S Dalzero and Enrica Tamburrini",

year = "2010",

doi = "10.1310/hct1106-303",

language = "English",

volume = "11",

pages = "303--311",

journal = "HIV Clinical Trials",

issn = "1528-4336",

publisher = "Taylor and Francis Ltd.",

number = "6",

}

TY - JOUR

T1 - Treatment change in pregnancy is a significant risk factor for detectable HIV-1 RNA in plasma at end of pregnancy

AU - Floridia, M

AU - Ravizza, M

AU - Pinnetti, Carmela

AU - Tibaldi, C

AU - Bucceri, A

AU - Anzidei, G

AU - Fiscon, M

AU - Molinari, Alessandra

AU - Martinelli, P

AU - Dalzero, S

AU - Tamburrini, Enrica

PY - 2010

Y1 - 2010

N2 - To investigate the risk factors for an HIV-1 RNA plasma viral load above 400 copies/mL in the third trimester of pregnancy.

AB - To investigate the risk factors for an HIV-1 RNA plasma viral load above 400 copies/mL in the third trimester of pregnancy.

KW - Adult

KW - Anti-Retroviral Agents

KW - CD4 Lymphocyte Count

KW - Cohort Studies

KW - Drug Administration Schedule

KW - Female

KW - HIV Infections

KW - HIV-1

KW - Humans

KW - Infant

KW - Infectious

KW - Infectious Disease Transmission

KW - Logistic Models

KW - Newborn

KW - Pregnancy

KW - Pregnancy Complications

KW - Pregnancy Trimester

KW - RNA

KW - Risk Factors

KW - Third

KW - Time Factors

KW - Vertical

KW - Viral

KW - Viral Load

KW - Withholding Treatment

KW - Young Adult

KW - Adult

KW - Anti-Retroviral Agents

KW - CD4 Lymphocyte Count

KW - Cohort Studies

KW - Drug Administration Schedule

KW - Female

KW - HIV Infections

KW - HIV-1

KW - Humans

KW - Infant

KW - Infectious

KW - Infectious Disease Transmission

KW - Logistic Models

KW - Newborn

KW - Pregnancy

KW - Pregnancy Complications

KW - Pregnancy Trimester

KW - RNA

KW - Risk Factors

KW - Third

KW - Time Factors

KW - Vertical

KW - Viral

KW - Viral Load

KW - Withholding Treatment

KW - Young Adult

UR - https://publicatt.unicatt.it/handle/10807/25072

U2 - 10.1310/hct1106-303

DO - 10.1310/hct1106-303

M3 - Article

SN - 1528-4336

VL - 11

SP - 303

EP - 311

JO - HIV Clinical Trials

JF - HIV Clinical Trials

IS - 6

ER -

Treatment change in pregnancy is a significant risk factor for detectable HIV-1 RNA in plasma at end of pregnancy

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this